NEUROEPIDEMIOLOGY expert and epileptologist Associate Professor Wendyl D'Souza has joined an Advisory Board run by ASX-listed medicinal cannabis firm MGC Pharma.
D'Souza will lead research and development into medicinal cannabis treatments for epilepsy and other neurological disorders.
The above article was sent to subscribers in Pharmacy Daily's issue from 01 Aug 18
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 01 Aug 18